Cardio-Oncology: The Intersection Between Cardiovascular Disease and Cancer

Cardio-oncology is a rapidly emerging field, and advanced practitioners (APs) play key roles in the prevention, early detection, and optimal treatment of cardiotoxicities associated with cancer therapies. At JADPRO Live Virtual 2020, Jessica Shank Coviello, DNP, APRN, ANP-BC, and Kejal Amin, PharmD,...

Descripción completa

Detalles Bibliográficos
Autores principales: Coviello, Jessica Shank, Amin, Kejal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2021
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087219/
https://www.ncbi.nlm.nih.gov/pubmed/34084569
http://dx.doi.org/10.6004/jadpro.2021.12.3.6
_version_ 1783686626770157568
author Coviello, Jessica Shank
Amin, Kejal
author_facet Coviello, Jessica Shank
Amin, Kejal
author_sort Coviello, Jessica Shank
collection PubMed
description Cardio-oncology is a rapidly emerging field, and advanced practitioners (APs) play key roles in the prevention, early detection, and optimal treatment of cardiotoxicities associated with cancer therapies. At JADPRO Live Virtual 2020, Jessica Shank Coviello, DNP, APRN, ANP-BC, and Kejal Amin, PharmD, MBA, BCOP, reviewed patient risk factors and cardiovascular therapeutic agents that APs should be aware of.
format Online
Article
Text
id pubmed-8087219
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-80872192021-06-02 Cardio-Oncology: The Intersection Between Cardiovascular Disease and Cancer Coviello, Jessica Shank Amin, Kejal J Adv Pract Oncol Meeting Reports Cardio-oncology is a rapidly emerging field, and advanced practitioners (APs) play key roles in the prevention, early detection, and optimal treatment of cardiotoxicities associated with cancer therapies. At JADPRO Live Virtual 2020, Jessica Shank Coviello, DNP, APRN, ANP-BC, and Kejal Amin, PharmD, MBA, BCOP, reviewed patient risk factors and cardiovascular therapeutic agents that APs should be aware of. Harborside Press LLC 2021-04 2021-04-01 /pmc/articles/PMC8087219/ /pubmed/34084569 http://dx.doi.org/10.6004/jadpro.2021.12.3.6 Text en © 2021 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Coviello, Jessica Shank
Amin, Kejal
Cardio-Oncology: The Intersection Between Cardiovascular Disease and Cancer
title Cardio-Oncology: The Intersection Between Cardiovascular Disease and Cancer
title_full Cardio-Oncology: The Intersection Between Cardiovascular Disease and Cancer
title_fullStr Cardio-Oncology: The Intersection Between Cardiovascular Disease and Cancer
title_full_unstemmed Cardio-Oncology: The Intersection Between Cardiovascular Disease and Cancer
title_short Cardio-Oncology: The Intersection Between Cardiovascular Disease and Cancer
title_sort cardio-oncology: the intersection between cardiovascular disease and cancer
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087219/
https://www.ncbi.nlm.nih.gov/pubmed/34084569
http://dx.doi.org/10.6004/jadpro.2021.12.3.6
work_keys_str_mv AT coviellojessicashank cardiooncologytheintersectionbetweencardiovasculardiseaseandcancer
AT aminkejal cardiooncologytheintersectionbetweencardiovasculardiseaseandcancer

Ejemplares similares